GRAMD1B and cancer: Therefore, we speculate that upregulation of GRAMD1B, despite causing decreased SREBP-2 activation and cholesterol biosynthesis, would be beneficial for cancer cells, as it could support their increased uptake, storage, and use of exogenous cholesterol.